Pharmaceutical waste can result from many activities and locations in a healthcare facility. If you have a compounding pharmacy on site, it generates drug waste. Anywhere medicines are employed can be the site of spills, half-used bottles, and IV equipment with residual medicine on it. Waste pharmaceuticals can pose a special treatment and management challenge. Small quantities at households can often be thrown away in the municipal waste stream (perhaps with some makeshift method of denaturing or making the drugs undesirable to interlopers). Large quantities kept at pharmacies, distribution centers, hospitals, etc. must be managed to minimize the risk of release or to exposure to workers and the public.
This category of waste includes expired, unused, and contaminated pharmaceutical products including vaccines and biological products used for therapy. Prescription and over-the-counter drugs end up as pharmaceutical waste as does paraphernalia used in pharmacies: gloves, masks, bottles, etc. Medicines that are made through biotechnology are referred to as biopharmaceuticals, or biologics.
In the past, health care facilities would routinely flush waste pharmaceuticals down the drain. As a society we didn’t know how detrimental these drugs would be to the environment. Now biologists have found residual pharmaceuticals in fish and other aquatic organisms, and we are understanding how bad the untreated disposal of drugs is. As responsible citizens and waste managers, we need to keep the Precautionary Principle in mind.
Pharmaceutical wastes can be hazardous under RCRA, but in many cases they are not. Just because materials do not meet the RCRA standards does not mean they are not hazardous in the common sense meaning of hazardous. Project Greenhealth says that "approximately 10% of the drugs that are not technically subject to the hazardous waste regulations are equally hazardous under RCRA criteria." Solid pharmaceutical waste is generally easy to handle and package, but liquid waste poses more challenges in confining the waste and minimizing risk of release.
Unused medicines in their original unopened packages can often be returned to the supplier you bought it from. This is win-win. You don’t have to dispose of the drugs as waste and someone else who needs the medicine can use it.
USP 800 is a standard and guideline for handling and managing dangerous pharmaceuticals. It was promulgated by the United States Pharmacopeial Convention in 2019. It specifies PPE that workers should wear, safe working procedures, and engineering controls to reduce the risk of exposure. The guidelines are reasonable and make sense, and we encourage everyone who works with genotoxic drugs to follow them.
Pharmaceuticals encompass a huge range of chemical compounds and they have all sorts of different effects on humans, animals, and plants. You need to be careful with all of them. Some medicines, such as those used to treat cancer, are outright dangerous (genotoxic or cytotoxic) and healthcare workers have to be protected from exposure. Pharmaceutical wastes can be irritants to body tissues.
Outside of their biological properties, pharmaceutical wastes can be hazardous the same way many chemicals are. They can be ignitable, corrosive, or highly reactive. Some drugs are genotoxic or mutagenic - aside from being dangerous to release to the environment, these can cause cancer and reproductive problems in healthcare workers. Medical facilities that deal with cancer treatment produce carcinogenic and/or teratogenic waste.
Pharmaceuticals that meet the federal definition of hazardous waste (under the Resource Conservation and Recovery Act), must be managed accordingly. Materials in the pharmacy that may constitute hazardous waste include carrier solvents like phenol. Drugs that dirupt endocrine gland function or embryonic and fetal development are of concern even though they do not meet the RCRA criteria. Also, many drugs do not meet the RCRA criteria for toxicity, but are of concern and which responsible waste management calls for attention. This includes vitamin or mineral supplements that contain chromium, selenium or cadmium, as well as drugs that are considered carcinogenic as defined by the National Toxicology Program.
Botox (Botulinum toxin) and items contaminated with it are also hazardous waste, and should be placed in the pharmaceutical waste stream.
There are exceptions for household waste, but enterprises (commercial and non-profit alike) cannot dispose of drugs by putting them in the municipal waste stream for delivery to a landfill. In the US, the EPA’s Land Disposal Restriction requires treatment of pharmaceuticals before disposal.
Treatment is aimed at changing the chemical structure of the medicines. The treated medicine should be packaged for disposal with no worries of it getting into the ecosystem and harming people. While any number of chemical reactions could be proposed and systems devised to deliver those reactions (think of a giant artificial liver), a more foolproof, all-encompassing solution is incineration.
Incineration induces chemical reactions, too. Combustion is oxidation of anything that will burn, and most pharmaceuticals are organic compounds that will burn with sufficient temperature, oxygen, and time. A few drugs such as arsenic oxide are inorganic.
Many common drugs that do not fit the criteria for RCRA hazardous waste include antidepressants, antihypertensives, hormones, and antibiotics. Although there is no special requirement that they be treated before disposal, healthcare facilities that have these items in their waste streams generally want to treat them to reduce liability. These can all be incinerated. Dietary supplements containing heavy metals are also inappropriate for incineration. These can probably be put in the MSW stream, but encapsulation is also an alternative and the waste manager may choose this alternative just to be sure and to reduce liability.
Incineration is thus an appealing option for the waste management engineer with a heterogeneous waste stream, as many streams with pharmaceuticals tend to be. Alkaline hydrolysis (mixing with a strong solution of sodium hydroxide) can also work on a wide range of pharmaceuticals. The system never gets hot and avoids the problems incinerators can come with (e.g. ash, acid gases in the flue stream, need to cool flue gas.) Because the reactants and their products do not go into the gas phase, the kinetics of the oxidation is slower and inadequate mixing may limit the effectiveness of the destruction.
Alkaline hydrolysis is an un-nuanced blunt technology that destroys a lot of things. It is used to decompose animal carcasses. Given the unpopularity of incineration in many cases, the appeal of hydrolysis is clear. There is no air pollution, no chance of dioxin formation, no greenhouse gases, temperatures comparable to a kitchen (and hence less dangerous than an incinerator). For all practical purposes, both technologies work. Alkaline hydrolysis results in a lot more secondary waste that must be dealt with - high pH liquid slurry and maybe solid residue versus incinerator ash. But there is also no air permit required.
Encapsulation leaves hazardous materials unchanged but prevents them from seeping into the environment. Encapsulation is accomplished with many plastics, resins, and even concrete.
The concrete process is appealing because it is inexpensive and can be done with readily obtained equipment. Other than personnel, the main requirements are a grinder or road roller to crush the pharmaceuticals, a concrete mixer and supplies of cement, lime and water.
This disposal process involves removing the pills (this is not often used on liquid medication) from the packaging (and that includes taking the pills out of blister packs). The pills are then ground mixed with lime and cement and water into a paste. The following are typical proportions (by weight) for the mixture:
The WHO recommends putting the moist paste into the landfill before it dries, but there appears to be no reason for that. It could be allowed to dry before transport to the landfill. In any case this concrete is thought to be safe enough to put into a sanitary landfill with municipal solid waste. Leaching is still a possibility, but if the landfill is a sanitary landfill, the chances of that should be reduced.
The UK government requires that controlled drugs be denatured before disposal. Denature means changing the physical/chemical characteristics so the drug is ineffective. It can often be done by mixing the medicine with a strong acid or oxidizer such as bleach. Even if you do not live in the UK, this may be a good idea and can reduce your liability.
Waste is considered hazardous because it either (1) contains materials on canonical lists - the F, K, P, and U lists - that are elaborated in the code of federal regulations, or (2) has the RCRA characteristics. The RCRA characteristics:
The P-list includes eight chemical compounds used as drugs. These are "acutely hazardous" with a lethal dose (oral administration) of 50 mg/kg patient weight or less. The compounds are Warfarin (P001), Nitroglycerin (P081), Physostigmine (P204) and Physostigmine salicylate (P188), Nicotine (P075), Phentermine (P046), Arsenic trioxide (P012), and Epinephrine (P042). Waste Epinephrine is the most common of these in most hospitals.
The U-list includes 20 chemical compounds used as drugs.
Project Greenhealth says that the fact that RCRA is over 40 years old means it has not kept up with healthcare and that "pharmaceuticals that are not technically RCRA hazardous waste when discarded should be analyzed for their potential to cause harm to human health and the environment."
Chemotherapy medicines are notoriously dangerous, but only nine chemotherapy drugs are either P- or U- listed chemicals. These nine were in use in 1976. Therefore, over 100 equally hazardous chemotherapy drugs currently in use today are not identified federally as hazardous waste and are not subject to the RCRA Subtitle C requirements. However, a good deal of chemotherapy waste must be managed as hazardous waste because of their toxicity.
Mineral preparations with heavy metals can be classified as hazardous waste.
There is a tempatation in healthcare settings to flush non-hazardous pharmaceutical waste down the drain. These materials include vitamins, syrups, aspirin, etc. We encourage facilities to NOT do this. You have a waste disposal system available, and even though disposal of non-hazardous materials through it costs money, we think you should take care of the waste that way. Project Greenhealth says: "best management practices [call for] managing drugs that are equally harmful as hazardous waste when discarded and managing all other drug waste through incineration."
Can I put pharmaceutical waste in my hazardous waste containers?
If you have a contractor that takes away your RCRA waste and they agree to take pharmaceutical waste, you can do this. However, it is not a "best practice".
The US government’s Secure and Responsible Drug Disposal Act of 2010 encouraged the growth of take-back programs, Retail pharmacies are now permitted to keep collection boxes at long-term care facilities. Manufacturers and distributors are also permitted to have mail-based take-back programs and to maintain collection boxes but most do not. Retail pharmacies generally will do so, even if you didn’t buy the medicine from that pharmacy. The federal government has a webpage that helps you find pharmacies that will take medicines in your area (in the United States). A medical waste company hauls away from accumulated medicine periodically and it is ultimately incinerated.
The federal government, especially the Drug Enforcement Agency and Food and Drug Administation, keeps an eye on drugs that are returned. There are regulations for reverse distributors, and the Drug Enforcement Agency has a registration program for them. The DEA's list of registered reverse distributors.
Drugs are used in treatment of cancer, but some drugs also can cause cancer - or at least increase the risk of cancer. The list of carcinogenic medicines includes some chemotherapy agents. Other chemicals used in healthcare settings can also cause cancer.
Carcinogens pose a problem in medical waste and a risk for workers, patients, and visitors to health care facilities. Here is a list that the National Institute for Occupational Safety and Health (NIOSH) developed of hazardous chemotherapy drugs.
Related: Naming Conventions for Medicines